chlorpromazine has been researched along with moxisylyte in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Sugden, RF | 1 |
| Speiser, Z; Weinstock, M | 1 |
| Pedersen, E | 1 |
| Gingell, JC | 1 |
2 review(s) available for chlorpromazine and moxisylyte
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New developments in self-injection therapy for erectile dysfunction.
Topics: Alprostadil; Calcitonin Gene-Related Peptide; Chlorpromazine; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Injections; Male; Moxisylyte; Papaverine; Patient Satisfaction; Phentolamine; Self Administration; Sympatholytics; Treatment Outcome; Vasoactive Intestinal Peptide; Vasodilator Agents | 1998 |
6 other study(ies) available for chlorpromazine and moxisylyte
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
The action of indoramin and other compounds on the uptake of neurotransmitters into rat cortical slices.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Benzamides; Brain; Brain Chemistry; Chlorobenzenes; Chlorpromazine; Imipramine; In Vitro Techniques; Indoles; Moxisylyte; Neurotransmitter Agents; Norepinephrine; Phentolamine; Piperidines; Pyrimidines; Rats; Serotonin; Serotonin Antagonists; Synaptic Transmission | 1974 |
Modification by propranolol and related compounds of motor activity and stereotype behaviour induced in the rat by amphetamine.
Topics: Amphetamine; Animals; Behavior; Chlorpromazine; Dose-Response Relationship, Drug; Humans; Male; Motor Activity; Moxisylyte; Norepinephrine; Oxprenolol; Practolol; Propranolol; Rats; Spiperone; Stereotyped Behavior; Stimulation, Chemical | 1974 |
Management of spasticity on neurophysiological basis.
Topics: Baclofen; Chlorpromazine; Cryosurgery; Curare; Dantrolene; Diazepam; Humans; Moxisylyte; Muscle Spasticity; Neuromuscular Nondepolarizing Agents; Propranolol; Reflex | 1980 |